Latest Clinical Laserthermia Systems News & Updates

See the latest news and media coverage for CLS. We track all announcements, press releases, and industry mentions in real time, all in one place.

Clinical Laserthermia Systems (CLS)

Developer of laser ablation systems for cancer and neurosurgery

Latest news about Clinical Laserthermia Systems (CLS)

February 20 CLS

CLS presents the Q4 report today

CEO Dan Mogren and CFO Katarina Lundqvist will hold the presentation at 1 PM, followed by Q&A with Redeye analyst Gustaf Meyer.
January 8 CLS

CLS announces first three patients treated with TRANBERG system

The treatments occurred at Andros Clinic in the Netherlands, marking a step in expanding FLA adoption across Europe. FLA offers better functional outcomes than radical prostatectomy.
3 December 2025 CLS

CLS submits CE marking application for ClearPoint Prism

Milestone follows successful brain tumor study and ISO certification. LITT platform shows safety, ease, and survival benefits. Aims for European commercial launch.
25 June 2024 CLS

CLS summarizes June 2024 newsletter achievements

Highlights neurology successes with ClearPoint Prism launch, US market expansion, new orders, and urology clinical data plus partnerships. CEO emphasizes neurosurgery focus.

April 28 FinanzNachrichten

Clinical Laserthermia Systems AB: CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT

Clinical Laserthermia Systems AB (CLS) today announced it has reached an agreement with its strategic partner on an alignment to accelerate the growth of the...
February 20 FinanzNachrichten

Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2025

Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its Year-end report for January - December 2025.Highlights of the Year-end...
12 December 2025 FinanzNachrichten

Clinical Laserthermia Systems AB: CLS initiates recruitment process for permanent Chief Financial Officer

Clinical Laserthermia Systems AB (publ) ("CLS") today announces that the company has decided to transition from its current interim, part-time consulting CFO arrangement to a...
4 September 2025 TradingView

Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[®] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT

CLSLund, Sweden - September 4th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") today announced that the U.S. Food and Drug Administration...

Never miss news about CLS

Track CLS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Discover what's making headlines across other trending companies.